Involvement of tissue plasminogen activator in stress responsivity during acute cocaine withdrawal in mice

References

• Ambrosio E, Sharpe LG, Pilotte NS. 1997. Regional binding to corticotropin releasing factor receptors in brain of rats exposed to chronic cocaine and cocaine withdrawal. Synapse. 25:272–276.
   Google Scholar
• Aouizerate B, Ho A, Schluger JH, Perret G, Borg L, Le Moal M, Piazza PV, Kreek MJ. 2006. Glucocroticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: Dose-response to dexamethasone suppression. Addict Biol. 11:84–96.
   Google Scholar
• Back SE, Hartwell K, Desantis SM, Saladin M, McRae-Clark AL, Price KL, Moran-Santa Maria MM, Baker NL, Spratt E, Kreek MJ, Brady KT. 2010. Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend. 106:21–27.
   PubMed Web of Science ®Google Scholar
• Bahi A, Dreyer JL. 2008. Overexpression of plasminogen activators in the nucleus accumbens enhances cocaine-, amphetamine- and morphine-induced reward and behavioral sensitization. Genes Brain Behav. 7:244–256.
   PubMed Web of Science ®Google Scholar
• Baranes D, Lederfein D, Huang YY, Chen M, Bailey CH, Kandel ER. 1998. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron. 21:813–825.
   PubMed Web of Science ®Google Scholar
• Basso AM, Spina M, Rivier J, Vale W, Koob GF. 1999. Corticotropin-releasing factor antagonist attenuates the “anxiogenic-like” effect in the defensive burying paradigm but not in elevated plus-maze following chronic cocaine in rats. Psychopharmacology. 145:21–30.
   PubMed Web of Science ®Google Scholar
• Baumann MH, Gendron TM, Becketts KM, Henningfield JE, Gorelick DA, Rothman RB. 1995. Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers. Biol Psychiatry. 38:751–755.
   PubMed Web of Science ®Google Scholar
• Befort K, Filliol D, Ghate A, Darcq E, Matifas A, Muller J, Lardenois A, Thibault C, Dembele D, Le Merrer J, Becker J, Poch O, Kieffer B. 2008. Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala. Eur J Neurosci. 27:2973–2984.
   Google Scholar
• Borowsky B, Kuhn CM. 1991. Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses. Brain Res. 543:301–306.
   Google Scholar
• Brady KT, McRae AL, Moran-Santa Maria MM, DeSantis SM, Simpson AN, Waldrop AE, Back SE, Kreek MJ. 2009. Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals. Arch Gen Psychiatry. 66:422–430.
   Google Scholar
• Carrasco GA, Van de Kar LD, Sullivan NR, Landry M, Garcia F, Muma NA, Battaglia G. 2006. Cocaine-mediated supersensitivity of 5-HT2A receptors in hypothalamic paraventricular nucleus is a withdrawal-induced phenomenon. Neuroscience. 143:7–13.
   PubMed Web of Science ®Google Scholar
• Centonze D, Napolitano M, Saulle E, Gubellini P, Picconi B, Martorana A, Pisani A, Gulino A, Bernardi G, Calabresi P. 2002. Tissue plasminogen activator is required for corticostriatal long-term potentiation. Eur J Neurosci. 16:713–721.
   Google Scholar
• Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156–159.
   PubMed Web of Science ®Google Scholar
• Cleck JN, Ecke LE, Blendy JA. 2008. Endocrine and gene expression changes following forced swim stress exposure during cocaine abstinence in mice. Psychopharmacology. 201:15–28.
   Google Scholar
• Gualandris A, Jones TE, Strickland S, Tsirka SE. 1996. Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J Neurosci. 16:2220–2225.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Kajii Y, Nishikawa T. 1998. Psychotomimetic-induction of tissue plasminogen activator mRNA in corticostriatal neurons in rat brain. Eur J Neurosci. 10:3387–3399.
   Google Scholar
• Iredale PA, Alvaro JD, Lee Y, Terwilliger R, Chen YL, Duman RS. 2000. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal. J Neurochem. 74:199–208.
   PubMed Web of Science ®Google Scholar
• Jacobsen LK, Giedd JN, Kreek MJ, Gottschalk C, Kosten TR. 2001. Quantitative medial temporal lobe brain morphology and hypothalamic-pituitary-adrenal axis function in cocaine dependence: A preliminary report. Drug Alcohol Depend. 62:49–56.
   Google Scholar
• Koob GF. 2008. A role for brain stress systems in addiction. Neuron. 59:11–34.
   PubMed Web of Science ®Google Scholar
• Koob GF, Kreek MJ. 2007. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 164:1149–1159.
   PubMed Web of Science ®Google Scholar
• Kreek MJ, Koob GF. 1998. Drug dependence: Stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 51:23–47.
   PubMed Web of Science ®Google Scholar
• Levy AD, Li Q, Alvarez Sanz MC, Rittenhouse PA, Kerr JE, Van de Kar LD. 1992. Neuroendocrine responses to cocaine do not exhibit sensitization following repeated cocaine exposure. Life Sci. 51:887–897.
   Google Scholar
• Maiya R, Zhou Y, Norris E, Kreek MJ, Strickland S. 2009. Tissue plasminogen activator modulates the cellular and behavioral response to cocaine. Proc Natl Acad Sci USA. 106:1983–1988.
   Google Scholar
• Mantsch JR, Taves S, Khan T, Katz ES, Sajan T, Tang LC, Cullinan WE, Ziegler DR. 2007. Restraint-induced corticosterone secretion and hypothalamic CRH mRNA expression are augmented during acute withdrawal from chronic cocaine administration. Neurosci Lett. 415:269–273.
   Google Scholar
• Markou A, Kosten TR, Koob GF. 1998. Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology. 18:135–174.
   PubMed Web of Science ®Google Scholar
• Matys T, Pawlak R, Matys E, Pavlides C, McEwen BS, Strickland S. 2004. Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior. Proc Natl Acad Sci USA. 101:16345–16350.
   PubMed Web of Science ®Google Scholar
• McNally GP, Akil H. 2002. Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory and endocrine consequences of opiate withdrawal. Neuroscience. 112:605–617.
   Google Scholar
• Mendelson JH, Teoh SK, Mello NK, Ellingboe J, Rhoades E. 1992. Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men. J Pharmacol Exp Ther. 263:505–509.
   PubMed Web of Science ®Google Scholar
• Mendelson JH, Sholar M, Mello NK, Teoh SK, Sholar JW. 1998. Cocaine tolerance: Behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology. 18:263–271.
   PubMed Web of Science ®Google Scholar
• Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, Weiss F. 1995. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci. 15:5439–5447.
   PubMed Web of Science ®Google Scholar
• Miczek KA, Covington HE3rd, Nikulina EMJr, Hammer RP. 2004. Aggression and defeat: Persistent effects on cocaine self-administration and gene expression in peptidergic and aminergic mesocorticolimbic circuits. Neurosci Biobehav Rev. 27:787–802.
   Google Scholar
• Moldow RL, Fischman AJ. 1987. Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone. Peptides. 8:819–822.
   PubMed Web of Science ®Google Scholar
• Nagai T, Yamada K, Yoshimura M, Ishikawa K, Miyamoto Y, Hashimoto K, Noda Y, Nitta A, Nabeshima T. 2004. The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. Proc Natl Acad Sci USA. 101:3650–3655.
   Google Scholar
• Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A. 2001. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med. 7:59–64.
   PubMed Web of Science ®Google Scholar
• Norris EH, Strickland S. 2007. Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system. Proc Natl Acad Sci USA. 104:13473–13478.
   Google Scholar
• Olive MF, Koenig HN, Nannini MA, Hodge CW. 2002. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav. 72:213–220.
   Google Scholar
• Pawlak R, Magarinos AM, Melchor J, McEwen B, Strickland S. 2003. Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nat Neurosci. 6:168–174.
   PubMed Web of Science ®Google Scholar
• Peltier RL, Guerin GF, Dorairaj N, Goeders NE. 2001. Effects of saline substitution on responding and plasma corticosterone in rats trained to self-administer different doses of cocaine. J Pharmacol Exp Ther. 299:114–120.
   Google Scholar
• Piazza PV, Le Moal M. 1997. Glucocorticoids as a biological substrate of reward: Physiological and pathophysiological implications. Brain Res Rev. 25:359–372.
   PubMedGoogle Scholar
• Richter RM, Weiss F. 1999. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse. 32:254–261.
   PubMed Web of Science ®Google Scholar
• Richter RM, Pich EM, Koob GF, Weiss F. 1995. Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci Lett. 187:169–172.
   Google Scholar
• Ripley TL, Rocha BA, Oglesby MW, Stephens DN. 1999. Increased sensitivity to cocaine, and over-responding during cocaine self-administration in tPA knockout mice. Brain Res. 826:117–127.
   Google Scholar
• Rivier C, Vale W. 1987. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res. 422:403–406.
   PubMed Web of Science ®Google Scholar
• Rodriguez de Fonseca F, Carrera MR, Navarro M, Koob GF, Weiss F. 1997. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science. 276:2050–2054.
   PubMed Web of Science ®Google Scholar
• Rudoy CA, Reyes AR, Van Bockstaele EJ. 2009. Evidence for beta (1)-adrenergic receptor involvement in amygdalar corticotropin-releasing factor gene expression: Implications for cocaine withdrawal. Neuropsychopharmacology. 34:1135–1148.
   Google Scholar
• Samson AL, Medcalf RL. 2006. Tissue-type plasminogen activator: A multifaceted modulator of neurotransmission and synaptic plasticity. Neuron. 50:673–678.
   Google Scholar
• Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G. 1995. Brain corticotropin-releasing factor mediates ‘anxiety-like’ behavior induced by cocaine withdrawal in rats. Brain Res. 675:89–97.
   PubMedGoogle Scholar
• Sarnyai Z, Dhabhar FS, McEwen BS, Kreek MJ. 1998. Neuroendocrine-related effects of long-term, “binge” cocaine administration: Diminished individual differences in stress-induced corticosterone response. Neuroendocrinology. 68:334–344.
   Google Scholar
• Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ. 2003. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology. 170:62–72.
   PubMed Web of Science ®Google Scholar
• Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ. 2006. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry. 63:324–331.
   PubMed Web of Science ®Google Scholar
• Smith RJ, Aston-Jones G. 2008. Noradrenergic transmission in the extended amygdala: Role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct. 213:43–61.
   PubMed Web of Science ®Google Scholar
• Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, Koob GF. 2002. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: Regulation by corticotropin-releasing factor. Alcohol Clin Exp Res. 26:1494–1501.
   PubMed Web of Science ®Google Scholar
• Vescovi PP, Coiro V, Volpi R, Passeri M. 1992. Diurnal variations in plasma ACTH, cortisol and beta-endorphin levels in cocaine addicts. Horm Res. 37:221–224.
   Google Scholar
• Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP, Valdez GR, Ben-Shahar O, Angeletti S, Richter RR. 2001. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann NY Acad Sci. 937:1–26.
   PubMed Web of Science ®Google Scholar
• Yamada K, Nagai T, Nabeshima T. 2005. Drug dependence, synaptic plasticity, and tissue plasminogen activator. J Pharmacol Sci. 97:157–161.
   Google Scholar
• Yan Y, Yamada K, Mizoguchi H, Noda Y, Nagai T, Nitta A, Nabeshima T. 2007. Reinforcing effects of morphine are reduced in tissue plasminogen activator-knockout mice. Neuroscience. 146:50–59.
   Google Scholar
• Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ. 1996. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during “binge”-pattern cocaine administration and chronic withdrawal. J Pharmacol Exp Ther. 279:351–358.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Spangler R, Ho A, Kreek MJ. Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic “binge” cocaine. Mol Brain Res. 2003a; 114:73–79.
   Google Scholar
• Zhou Y, Spangler R, Schlussman SD, Ho A, Kreek MJ. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic “binge” cocaine and withdrawal. Brain Res. 2003b; 964:187–199.
   PubMed Web of Science ®Google Scholar
• Zorrilla EP, Valdez GR, Weiss F. 2001. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology. 158:374–381.
   PubMed Web of Science ®Google Scholar